Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war
WSJ·2025-11-08 11:07并购交易概述 - 辉瑞公司在针对一家减肥初创公司的竞购战中胜出 [1] - 此次竞购战被描述为不寻常的 [1] - 辉瑞的竞争对手诺和诺德在此次竞购中落败 [1]